Since the prior studies have not resulted in an exact conclusion about vitamin D and its role in DR, we investigated the treatment of DME with an anti-VEGF agent, bevacizumab, in the presence of vitamin D deficiency. The gene discussed is VEGFA; the disease is vitamin D deficiency.